نتایج جستجو برای: haemophilia type a

تعداد نتایج: 13688984  

Journal: :Iranian journal of allergy, asthma, and immunology 2006
Hassan Mansouri Torghabeh Aliakbar Pourfathollah Mahmood Mahmoodian Shooshtari Zahra Rezaie Yazdi

Many investigations have proved relations between ABO blood groups with some diseases and factor VIII and von willebrand level in plasma. In this study we investigated a relation between ABO blood groups and factor VIII and IX inhibitors in 102 patients with haemophilia A and 48 patients with haemophilia B. The assay of inhibitor was done by Bethesda method. There were no relation between ABO b...

Journal: :Nepal journal of neuroscience 2022

Intracranial hemorrhage in patients with hemophilia is associated high mortality and morbidity. We report a case of 15 years old boy haemophilia A, who presented spontaneous acute subdural hematoma underwent craniotomy for clot evacuation. The patient also received Factor VIII infusions peri-operatively along other measures, to decrease blood loss. signs raised intracranial pressure mannitol in...

Journal: :Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 2013
M Á Fernández de Palencia Espinosa V Arocas Casañ B Garrido Corro A de la Rubia Nieto

BACKGROUND Acquired haemophilia is an uncommon condition caused by the development of clotting factor inhibitors. To eliminate them, immunosuppressive therapy with corticosteroids and cytotoxic drugs is required. METHODS We describe a case of rituximab use in acquired haemophilia refractory to conventional therapy in a 63 year old male patient with chronic hepatitis C virus infection who was ...

Journal: :Haemophilia : the official journal of the World Federation of Hemophilia 2004
P Arranz E Remor M Quintana A Villar J L Díaz M Moreno J Monteagudo A Ugarriza I Soto R Pérez J Chacón M García-Luaces A Cid I Balda M F López M J Gutíerrez E Martínez C Marrero M Prieto C Sedano R Vaca C Altisent F Hernández-Navarro

A haemophilia-specific health-related quality-of-life questionnaire (named 'Hemofilia-QoL') was developed to assess quality-of-life in adults with haemophilia, and was psychometrically tested. Seventy-three interviews with haemophilia patients and health care professionals were used to generate the items included in the questionnaire, and expert ratings on the items formulated were used to scre...

Journal: :Journal of the Belgian Society of Radiology 2019

Journal: :Haemophilia : the official journal of the World Federation of Hemophilia 2004
A C Nathwani A M Davidoff E G D Tuddenham

That gene therapy offers the promise of a cure for haemophilia was apparent more than a decade ago. After years of failure, substantial progress in the efficiency of gene transfer technology has recently resulted in impressive success in animal models with haemophilia. However, fears of the risks intrinsic to such therapy have been raised by the fate of two children cured of immune deficiency b...

Journal: :British journal of anaesthesia 2003
P Dhar S Abramovitz D DiMichele C B Gibb F Gadalla

Haemophilia A is a bleeding disorder that has a spectrum of manifestations ranging from persistent bleeding after minor trauma to spontaneous haemorrhage. As an X-linked disease, it has a rare occurrence in females. We report a case of a pregnant patient with severe haemophilia A, who received epidural analgesia during labour. The prepartum, intrapartum and postpartum care of a patient with suc...

Journal: :British journal of haematology 2007
Leslie Raffini Catherine Manno

Currently available factor concentrates for treatment of patients with haemophilia are virally inactivated or are made by recombinant technology and their broad use in developed nations has resulted in the dramatic elimination of the treatment-related viral illnesses that decimated the haemophilia community in the late 20th century. The major morbidity experienced by patients with haemophilia t...

Journal: :British journal of haematology 2004
Alok Srivastava

The mainstay of the management of haemophilia is the replacement of clotting factors, using clotting factor concentrates (CFC) in a way that prevents bleeding and its complications. Beginning with small doses, as whole blood and plasma over 50 years ago, highly purified CFCs are now administered frequently in large doses to effectively treat this condition so that even people with severe haemop...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید